Related references
Note: Only part of the references are listed.Increased DHEAS and Decreased Total Testosterone Serum Levels in a Subset of Men with Early-Onset Androgenetic Alopecia: Does a Male PCOS-Equivalent Exist?
Rossella Cannarella et al.
International Journal of Endocrinology (2020)
Galectin-3 as a Next-Generation Biomarker for Detecting Early Stage of Various Diseases
Akira Hara et al.
BIOMOLECULES (2020)
Assessment of serum galectin-3, methylated arginine and Hs-CRP levels in type 2 diabetes and prediabetes
Mehmet Nuri Atalar et al.
LIFE SCIENCES (2019)
Clinical Profile of Androgenic Alopecia and Its Association with Cardiovascular Risk Factors
Rita V. Vora et al.
INDIAN JOURNAL OF DERMATOLOGY (2019)
The Use of High Sensitivity C-Reactive Protein in Cardiovascular Disease Detection
Ana Rita Castro et al.
JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES (2018)
Androgenetic alopecia: a review
Francesca Lolli et al.
ENDOCRINE (2017)
Androgenetic alopecia as an indicator of metabolic syndrome and cardiovascular risk
Ragip Ertas et al.
BLOOD PRESSURE (2016)
Associations between cardiovascular disease risk factors and IL-6 and hsCRP levels in the elderly
Pawel Nadrowski et al.
EXPERIMENTAL GERONTOLOGY (2016)
Is galectin-3 a biomarker, a player-or both-in the presence of coronary atherosclerosis?
Gokhan Aksan et al.
JOURNAL OF INVESTIGATIVE MEDICINE (2016)
A Comparison of the Hormonal Profile of Early Androgenetic Alopecia in Men With the Phenotypic Equivalent of Polycystic Ovarian Syndrome in Women
Sarita Sanke et al.
JAMA DERMATOLOGY (2016)
Inflammatory markers and Lp(a) levels as cardiovascular risk factors in androgenetic alopecia
Amparo Vaya et al.
CLINICAL HEMORHEOLOGY AND MICROCIRCULATION (2015)
Androgenetic alopecia is associated with increased arterial stiffness in asymptomatic young adults
M. T. Agac et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2015)
2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC)
Giuseppe Mancia et al.
JOURNAL OF HYPERTENSION (2013)
The investigation of insulin resistance and metabolic syndrome in male patients with early-onset androgenetic alopecia
Ceyda Mumcuoglu et al.
EUROPEAN JOURNAL OF DERMATOLOGY (2011)
Association of androgenetic alopecia with metabolic syndrome in men: a community-based survey
L-H. Su et al.
BRITISH JOURNAL OF DERMATOLOGY (2010)
The relationship between serum galectin-3 and serum markers of cardiac extracellular matrix turnover in heart failure patients
Yen-Hung Lin et al.
CLINICA CHIMICA ACTA (2009)
Different role of wave reflection magnitude and timing on left ventricular mass reduction during antihypertensive treatment
Junichiro Hashimoto et al.
JOURNAL OF HYPERTENSION (2008)
Targeted skin overexpression of the mineralocorticoid receptor in mice causes epidermal atrophy, premature skin barrier formation, eye abnormalities, and alopecia
Yannis Sainte Marie et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Obesity and low-grade inflammation among young Finnish men with early-onset alopecia
Paivi Hirsso et al.
DERMATOLOGY (2007)
Quantification of wave reflection in the human aorta from pressure alone - A proof of principle
Berend E. Westerhof et al.
HYPERTENSION (2006)
Androgenetic alopecia in men aged 40-69 years: prevalence and risk factors
G Severi et al.
BRITISH JOURNAL OF DERMATOLOGY (2003)
Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients
S Laurent et al.
HYPERTENSION (2001)
Male pattern baldness is not associated with established cardiovascular risk factors in the general population
JA Ellis et al.
CLINICAL SCIENCE (2001)
Early androgenetic alopecia as a marker of insulin resistance
V Matilainen et al.
LANCET (2000)
Male pattern baldness and coronary heart disease -: The physicians' health study
PA Lotufo et al.
ARCHIVES OF INTERNAL MEDICINE (2000)
Share Paper
